decoded.report LIVE FROM SEC FILINGS
CASE FILE · OPENED JUST FOR YOU

CRNX

Crinetics Pharmaceuticals, Inc.
LAST CLOSE… Pharmaceutical Preparations SHARES +13.2% · 12M CASH ~1 MO
43
GUARDED
RISK INDEX
RED FLAGS 14 SHARE PRINTING 8 RUNWAY 14 CASH DRAIN 5 YEARS-LONG PATTERN 2 = 43/100. WHY THIS NUMBER, PIECE BY PIECE.

THE READ 4 red-flag mentions across this year's filings, led by dilution, and 65 since 2001, so this is a long-running pattern; share count rose 13% over the past year; only about 1 month of cash at the current burn rate.

FLAGS DILUTION CASH WHAT CHANGED VERDICT INSIDERS OUTSIDE RECORDS
01

Red Flags

2025-08-30 → 2026-08-30

We read every document this company filed with the SEC this year and counted the classic danger phrases. Where wording can be misleading, we open the actual documents and separate real warnings from accounting boilerplate. Each hit links to the exact document.

Dilution (at the market offering) 4 REAL WARNINGS · 4 matching docS this year · 22 ALL TIME

An ATM lets the company print and sell new shares into the market any day it wants. Every print dilutes your slice.

EVIDENCE: [1] 424B5 FILED 2026-01-05 · [2] 424B5 FILED 2026-01-07 · [3] 10-Q FILED 2026-05-07 · [4] 10-Q FILED 2026-08-03

Reverse stock split 0 REAL WARNINGS · 1 matching doc this year · 16 ALL TIME

A reverse split shrinks the share count to lift the price above $1. Repeat reverse splits are the classic death-spiral signature.

EVIDENCE: [1] 8-K FILED 2026-07-06

Going concern doubt 0 THIS YEAR · 16 ALL TIME

Auditors flagged substantial doubt the company survives the next 12 months without new money.

Delisting / exchange risk 0 THIS YEAR · 11 ALL TIME

The exchange has threatened to kick the stock off. Delisting pressure usually ends in a reverse split or a fire-sale raise.

SOURCE: FULL-TEXT SEARCH OF THE COMPANY'S OFFICIAL SEC FILINGS. "REAL WARNINGS" = WE OPENED THE LINKED DOCUMENTS AND FILTERED PHRASES WRAPPED IN NEGATIONS, RESOLUTION LANGUAGE OR STANDARD CONTRACT TERMS. "AT LEAST" = MORE DOCUMENTS CARRY THE PHRASE THIS YEAR THAN WE COULD OPEN AND READ.

02

The Printing Press

How many shares exist, over time, exactly as the company reported in its own filings. In microcaps, a rising share count is how holders pay for everything: salaries, debts, and bad deals. Sudden collapses in the line are reverse splits, marked below.

24,024,231 shares · 2018-08-24 106,065,229 shares · 2026-07-22 LAST 12M: +13.2% AVG/YEAR SINCE 2018: +20.7% ◉ REVERSE-SPLIT-STYLE COLLAPSE × 1

SOURCE: THE COMPANY'S OWN REPORTED SHARE COUNTS ACROSS 33 FILINGS, STRAIGHT FROM SEC RECORDS

CHECKING OFFICIAL SPLIT RECORDS…

What this means for YOUR shares

Type how many shares you hold. The math is plain division on the company's own reported counts.

03

Cash Countdown

Cash in the bank against how fast the company burns it. When this hits zero, the next stop is usually a desperate raise at bad terms, and existing holders pay through dilution.

~1 MONTH OF CASH AT THE CURRENT BURNBAR = SHARE OF A 24-MONTH WINDOW
1 MO
EST RUNWAY
cash ÷ monthly burn
$37.02M
MONTHLY BURN
operating cash deficit
$55.50M
CASH ON HAND
latest reported quarter
-51.5%
CASH CHANGE QoQ
latest two reported quarters
2024·92024·122025·32025·62025·92025·122026·32026·6
CASH OVER TIME, LAST 8 REPORTED QUARTERS $317.27M → $55.50M TREND: -82.5%

RUNWAY = CASH ON HAND ÷ MONTHLY CASH BURN. SIMPLE ARITHMETIC ON THE COMPANY'S OWN REPORTED NUMBERS, NOT A PROJECTION.

04

What the Newest Filing Changed

The latest filings, translated into holder impact. Every number cites its form, date and SEC link.

Shares outstanding +0.6%

Shares outstanding rose 105.44M to 106.07M (+0.6%) between 10-Q 2026-04-23 and 10-Q 2026-07-22.

NOW: 106,065,229 as of 2026-07-22 (10-Q, filed 2026-08-03)

WAS: 105,440,208 as of 2026-04-23 (10-Q, filed 2026-05-07)

Cash and equivalents -51.5%

Cash and equivalents fell $114.34M to $55.50M (-$58.84M, -51.5%) between 10-Q 2026-03-31 and 10-Q 2026-06-30.

NOW: $55.50M as of 2026-06-30 (10-Q, filed 2026-08-03)

WAS: $114.34M as of 2026-03-31 (10-Q, filed 2026-05-07)

Total assets -5.7%

Total assets fell to $1.32B (from $1.40B, -5.7%) between 10-Q 2026-03-31 and 10-Q 2026-06-30.

NOW: $1.32B as of 2026-06-30 (10-Q, filed 2026-08-03)

WAS: $1.40B as of 2026-03-31 (10-Q, filed 2026-05-07)

Total liabilities +7.7%

Total liabilities rose to $129.92M (from $120.68M, +7.7%) between 10-Q 2026-03-31 and 10-Q 2026-06-30.

NOW: $129.92M as of 2026-06-30 (10-Q, filed 2026-08-03)

WAS: $120.68M as of 2026-03-31 (10-Q, filed 2026-05-07)

Revenue +134.0%

Revenue rose $10.73M to $25.12M (+134.0%) between the period ended 2026-03-31 and the period ended 2026-06-30 (10-Q).

NOW: $25.12M as of 2026-06-30 (10-Q, filed 2026-08-03)

WAS: $10.73M as of 2026-03-31 (10-Q, filed 2026-05-07)

Cash burn / runway

Monthly operating cash deficit ~$37.02M ($-218.90M over the period ended 2026-06-30 in 10-Q). Against $55.50M cash is roughly 0.1 years of runway (1 months).

NOW: $-218.90M as of 2026-06-30 (10-Q, filed 2026-08-03)

!

Critical 8-K Ledger

OFFICIAL NOTICES · 24 MO

When something material happens, the company itself must announce it in an 8-K under the SEC's numbered item system. These are those announcements, newest first: bankruptcy papers, exchange delisting warnings, auditor changes, financials pulled back. Read straight from the SEC filing index, no interpretation layer.

2026-07-10 ITEM 5.02 · OFFICER / DIRECTOR EXIT FILING ↗
2026-04-10 ITEM 5.02 · OFFICER / DIRECTOR EXIT FILING ↗
2026-03-23 ITEM 5.02 · OFFICER / DIRECTOR EXIT FILING ↗
2026-03-03 ITEM 4.01 · AUDITOR CHANGE FILING ↗
2026-01-26 ITEM 5.02 · OFFICER / DIRECTOR EXIT FILING ↗
2025-12-17 ITEM 5.02 · OFFICER / DIRECTOR EXIT FILING ↗
2025-04-04 ITEM 5.02 · OFFICER / DIRECTOR EXIT FILING ↗
2025-02-24 ITEM 5.02 · OFFICER / DIRECTOR EXIT FILING ↗
2024-12-16 ITEM 5.02 · OFFICER / DIRECTOR EXIT FILING ↗
2024-10-16 ITEM 5.02 · OFFICER / DIRECTOR EXIT FILING ↗
2024-09-17 ITEM 5.02 · OFFICER / DIRECTOR EXIT FILING ↗

SOURCE: THE ITEM NUMBERS THE COMPANY ITSELF PUT ON EACH 8-K IN THE SEC'S FILING INDEX. HOVER A STAMP FOR WHAT THAT ITEM MEANS FOR YOUR SHARES. OFFICIAL NOTICES INSIDE THE LAST 12 MONTHS ALSO FEED THE RISK INDEX ABOVE (CAPPED AT 15 POINTS).

2024·32024·62024·92025·32025·62025·92026·32026·6
QUARTERLY REVENUE, LAST 8 QUARTERS $640K → $25.12M TREND: +3824.7%

EACH BAR IS ONE REPORTED QUARTER. GREEN = MOST RECENT QUARTER GREW VS THE ONE BEFORE.

!

Breaking Filing

8-K · 2026-08-28

An 8-K is the "something happened right now" filing. Here is what this one says, in the company's own words.

Item 5.07

, a Delaware corporation (“Crinetics”), held a special meeting of shareholders (the “Special Meeting”) to consider and vote on the proposals set forth in the definitive proxy statement of Crinetics prepared in connection with the Merger (as defined below) filed with the U.S. Securities and Exchange Commission (the “SEC”) on July 31, 2026. At the Special Meeting, the total number of shares represented in person or by proxy was 79,264,631 of the 106,095,205 shares of common stock of Crinetics outstanding and entitled to vote at the Special Meeting as of the close of business on July 27, 2026, th...

READ THE ORIGINAL FILING

05

The Verdict

AVOID · HIGH CONFIDENCE

A rules-based reading of the cited filing facts: a range with reasons, never a prediction.

AVOID
SCREENING VERDICT
HIGH confidence
$5.62-$5.62
FAIR VALUE BRACKET
book equity of $11.24/share at 0.5-1.0x
$84.84
LAST CLOSE
non-realtime

HOW THE BRACKET IS BUILT: BOOK EQUITY OF $11.24/SHARE AT 0.5-1.0X · MULTIPLES STRIPPED: UNDER A YEAR OF CASH AT THE CURRENT BURN, SO THE BRACKET CAPS AT WIND-DOWN CASH · CASH FLOOR: $0.5232/SHARE IN A WIND-DOWN.

BASIS FOR

+1

Share count is stable-ish (+0.6% change between the last two reported quarters).

+2

Revenue grew 134.0% period over period, a bullish signal in the filings.

+3

Fair-value range anchored to cited facts: $5.62 to $5.62 per share.

AGAINST

−1

Cash of $55,498,000 funds under half a year of operating burn, a hard going-concern pressure without fresh capital.

METHOD: DETERMINISTIC RULES OVER CITED SEC FILING FACTS: SHARE-COUNT CHANGE BETWEEN THE LAST TWO REPORTED QUARTERS (DILUTION), CASH-TO-BURN RUNWAY FROM THE MOST RECENT OPERATING CASH FLOW, PERIOD-OVER-PERIOD REVENUE GROWTH, AND A FAIR-VALUE RANGE ANCHORED TO CASH PER SHARE VS PRICE. THRESHOLDS ARE TUNABLE IN APP/VERDICT_ENGINE.PY. NOT A PREDICTION.

06

Insider Paper Trail

NET SELLING

Every time an officer, director or big owner trades shares, the law makes them file a Form 4 within two business days. We read the actual filings: who traded, what kind of trade, how big, at what price.

0
OPEN-MARKET BUYS
nobody is buying with their own cash
1
OPEN-MARKET SELLS
3,000 shares · ~$120K cashed out
23
GRANTS / AWARDS
149,912 new shares/options handed out: future dilution
1/1
SELLS ON 10B5-1 PLANS
every sale was pre-scheduled in advance: less alarming than a discretionary dump
2026-022026-032026-042026-052026-062026-07
ABOVE THE LINE: CASH BUYS BELOW THE LINE: CASH SELLS 6 MO: +$0 / -$120K

EACH MONTH SHOWS OPEN-MARKET DOLLAR FLOW PARSED FROM FORM 4 FILINGS. GRANTS AND OPTION PAPER ARE EXCLUDED: THIS IS REAL MONEY IN AND OUT.

DATEWHOACTION
2026-08-20 Schilke Tobin CHIEF FINANCIAL & INFRA. GRANT/AWARD 471
2026-08-07 Struthers Richard Scott DIRECTOR OPTION EXERCISE 3,969 @ $25.19
2026-08-07 Struthers Richard Scott DIRECTOR OPTION EXERCISE 4,422 @ $22.61
2026-08-07 Struthers Richard Scott DIRECTOR OPTION EXERCISE 6,542 @ $15.29
2026-08-07 Struthers Richard Scott DIRECTOR OPTION EXERCISE 4,995 @ $20.02
2026-08-07 Struthers Richard Scott DIRECTOR OPTION EXERCISE 3,969 OPTIONS/DERIVATIVE
2026-08-07 Struthers Richard Scott DIRECTOR OPTION EXERCISE 4,422 OPTIONS/DERIVATIVE
2026-08-07 Struthers Richard Scott DIRECTOR OPTION EXERCISE 6,542 OPTIONS/DERIVATIVE
2026-08-07 Struthers Richard Scott DIRECTOR OPTION EXERCISE 4,995 OPTIONS/DERIVATIVE
2026-07-02 Vivaldi Coelho Rogerio DIRECTOR OPEN-MARKET SELL 3,000 @ $40.00 10B5-1 PLAN
2026-06-18 Deardorf Caren DIRECTOR GRANT/AWARD 5,925
2026-06-18 Deardorf Caren DIRECTOR GRANT/AWARD 9,730 OPTIONS/DERIVATIVE

PEOPLE WITH THE BEST INFORMATION ABOUT THIS COMPANY ARE SELLING MORE THAN THEY BUY. NOT PROOF OF ANYTHING: EXECUTIVES SELL FOR MANY REASONS. BUT AT MICROCAP SCALE, IT RARELY SMELLS GOOD. "10B5-1 PLAN" MEANS THE TRADE WAS SCHEDULED UNDER A PRE-SET TRADING PLAN, DISCLOSED IN THE FILING'S OWN FOOTNOTES: PRE-PLANNED SALES CARRY LESS SIGNAL THAN SPUR-OF-THE-MOMENT ONES. SOURCE: FORM 4 FILINGS, PARSED FROM THE SEC'S OWN XML, LAST 10 FILINGS.

07

Filing Timeline

The company's most recent SEC paperwork, newest first.

8-K 2026-08-28 0001140361-26-034857
4 2026-08-24 0001628280-26-058664
8-K 2026-08-19 0001140361-26-033738
8-K 2026-08-14 0001140361-26-032951
SCHEDULE 13G/A 2026-08-13 0000902219-26-000277
4 2026-08-11 0001628280-26-055700

SOURCE: THE COMPANY'S SEC FILING INDEX

08

Outside the Filings

Public records that most investors never check, cross-checked against what the company claims. This is where shells slip up.

crinetics.com
WEB ADDRESS ON RECORD
registered 2008-11-19 · via GoDaddy.com, LLC
17.8 YRS OLD
DOMAIN AGE
old and consistent with an operating company: a good sign
2
OFFICIAL OFFERING DOCS · 12M
last one 2026-01-07: shares were actually sold to the market
0
SHELF REGISTRATIONS · 12M
none filed: no dilution pipeline on record
0
BIG-OWNER TAKEOVER FILINGS · 12M
no outside investor has crossed the 5% disclosure line this year
PUBLIC FLOAT
shares actually tradable, vs held by insiders and big owners
SOLD SHORT
FINRA short interest: how many shares are bets against this company, and how many days of trading it would take to cover
CLEAR
US SANCTIONS SCREEN
company name checked against the official US sanctions list (19290 entries)
LEGAL IDENTITY (LEI)
every company that trades securities must carry a global legal identifier: status, parent chain and subsidiaries from the official registry
INSTITUTIONAL HOLDERS · 13F
quarterly institutional holdings filings scanned for this exact company name: which funds still report holding shares, from their own filings
SITE HISTORY
how long the company's website has been around, per the public web archive
CERT RECORD
public certificate logs date the company's web infrastructure: old and boring is good, brand-new is a tell
REGISTRANT HISTORY
old snapshots of public WHOIS pages: has the registered owner of this address changed hands
HOSTING + MAIL RECORDS
public DNS records: where the address is pointed and whether it can even receive mail

SOURCES: PUBLIC DOMAIN REGISTRATION RECORDS (FOUND IN THE COMPANY'S OWN FILING SIGNATURES) · THE COMPANY'S SEC FILING INDEX · OFFICIAL US SANCTIONS LIST · QUARTERLY 13F FILINGS VIA EDGAR FULL-TEXT SEARCH · LEGAL-IDENTITY, SITE-HISTORY, CERTIFICATE, REGISTRANT-HISTORY AND DNS SLOTS STREAM IN FROM FREE PUBLIC REGISTRIES WITHOUT BLOCKING THIS PAGE.

Others Under The Scanner

Real visitors who opened this case file also checked these tickers. Derived only from on-site search and watchlist activity of the last 90 days: no tracking, no cookies.

09

Company Record

Legal nameCrinetics Pharmaceuticals, Inc.
Fiscal year end1231
HQ6055 LUSK BLVD., SAN DIEGO, CA
Last periodic report2026-08-03 (10-Q, 27d ago)
Shares outstanding106,065,229 as of 2026-07-22 (10-Q)

SOURCE: THE COMPANY'S SEC FILING INDEX

Next time CRNX files something scary, know within minutes.

One Telegram message per material filing: dilution, going concern, delisting, insider dumps. No account, no email. Every line cites its SEC source. Leave anytime with /unwatch.

WATCH CRNX ON TELEGRAM →
+

Decode Another Ticker